Skip to content
LexBuild

Manufacturer of Controlled Substances; Notice of Application; Lin Zhi International Inc. 

---
identifier: "/us/fr/2012-12326"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances; Notice of Application; Lin Zhi International Inc."
title_number: 0
title_name: "Federal Register"
section_number: "2012-12326"
section_name: "Manufacturer of Controlled Substances; Notice of Application; Lin Zhi International Inc."
positive_law: false
currency: "2012-05-22"
last_updated: "2012-05-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2012-12326"
document_type: "notice"
publication_date: "2012-05-22"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "77 FR 30326"
fr_volume: 77
---

#  Manufacturer of Controlled Substances; Notice of Application; Lin Zhi International Inc.

Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 19, 2012, Lin Zhi International Inc., 670 Almanor Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

| Drug | Schedule |
| --- | --- |
| Tetrahydrocannabinols (7370) | I |
| 3,4-Methylenedioxymethamphetamine (7405) | I |
| Cocaine (9041) | II |
| Oxycodone (9143) | II |
| Hydrocodone (9193) | II |
| Methadone (9250) | II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) | II |
| Morphine (9300) | II |

The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 23, 2012.

Dated: May 15, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.